These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8465412)

  • 1. HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections.
    Gradoni L; Scalone A; Gramiccia M
    Trans R Soc Trop Med Hyg; 1993; 87(1):94-6. PubMed ID: 8465412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.
    Rezaei Z; Sarkari B; Dehghani M; Layegh Gigloo A; Afrashteh M
    Parasitol Res; 2018 Aug; 117(8):2591-2595. PubMed ID: 29860572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts.
    Kubar J; Marty P; Lelièvre A; Quaranta JF; Staccini P; Caroli-Bosc C; Le Fichoux Y
    AIDS; 1998 Nov; 12(16):2147-53. PubMed ID: 9833855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological screening of HIV and viral hepatitis revealed low prevalence among visceral leishmaniosis patients in Sudan.
    Abass E; Haroun A; Jomaa M
    Ann Parasitol; 2020; 66(2):135-141. PubMed ID: 32530590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of anti-Leishmania IgG3 and low CD4
    Kuschnir RC; Pereira LS; Dutra MRT; de Paula L; Silva-Freitas ML; Corrêa-Castro G; da Costa Cruz Silva S; Cota G; Santos-Oliveira JR; Da-Cruz AM
    BMC Infect Dis; 2021 Apr; 21(1):369. PubMed ID: 33874901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus.
    Berhe N; Hailu A; Wolday D; Negesse Y; Cenini P; Frommel D
    Trans R Soc Trop Med Hyg; 1995; 89(2):205-7. PubMed ID: 7778150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral leishmaniasis and HIV-1 co-infection in southern France.
    Rosenthal E; Marty P; Poizot-Martin I; Reynes J; Pratlong F; Lafeuillade A; Jaubert D; Boulat O; Dereure J; Gambarelli F
    Trans R Soc Trop Med Hyg; 1995; 89(2):159-62. PubMed ID: 7778140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of Leishmania infantum seropositivity in HIV/AIDS patients].
    Ozkan AT; Yalçinkaya T; Kiliç S; Babür C; Schallig HD
    Mikrobiyol Bul; 2008 Jan; 42(1):113-7. PubMed ID: 18444568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis in Somalia. Significance of IgG subclasses and of IgE response.
    Shiddo SA; Huldt G; Nilsson LA; Ouchterlony O; Thorstensson R
    Immunol Lett; 1996 Apr; 50(1-2):87-93. PubMed ID: 8793564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antileishmanial IgG antibodies and Leishmania-specific antigens in sera from Yemeni patients with visceral leishmaniasis.
    Azazy AA; Nasher ST; Ishaq A; Bin-Muhanna M; Chance ML
    Ann Trop Med Parasitol; 2003 Oct; 97(7):689-95. PubMed ID: 14613628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-fixed Leishmania chagasi promastigotes IgG antibodies detected by flow cytometry (FC-AFPA-IgG) as a tool for serodiagnosis and for post-therapeutic cure assessment in American visceral leishmaniasis.
    Garcia LM; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Teixeira-Carvalho A; Rocha RD; Araújo MS; Gomes IT; Carvalho SF; Dietze R; Lemos EM; Andrade MC; Martins-Filho OA
    J Immunol Methods; 2009 Oct; 350(1-2):36-45. PubMed ID: 19635482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The determination of the species specificity of Leishmania antibodies in different groups of human sera].
    Giboda M; Goncharov DB; Saf'ianova VM; Gracheva LI; Ditrich O
    Med Parazitol (Mosk); 1991; (3):29-32. PubMed ID: 1770880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leishmania infection and AIDS].
    Hernández Quero J; Carvajal Becerra F; Escobar Lara T; López Ruz MA; Vélez Bernal ID; de La Higuera JM
    An Med Interna; 1993 Jun; 10 Suppl():29-33. PubMed ID: 8507799
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-Leishmania co-infections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients.
    Gramiccia M; Gradoni L; Troiani M
    Trans R Soc Trop Med Hyg; 1992; 86(2):161-3. PubMed ID: 1440776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Visceral leishmaniasis and human immunodeficiency virus (HIV) infection in the south of France].
    Rosenthal E; Marty P; Cassuto JP
    Presse Med; 1995 Nov; 24(35):1666. PubMed ID: 8545394
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of anti-leishmania (Leishmania) chagasi immunoglobulin G by flow cytometry for cure assessment following chemotherapeutic treatment of American visceral leishmaniasis.
    Lemos EM; Gomes IT; Carvalho SF; Rocha RD; Pissinate JF; Martins-Filho OA; Dietze R
    Clin Vaccine Immunol; 2007 May; 14(5):569-76. PubMed ID: 17360851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy.
    Peters BS; Fish D; Golden R; Evans DA; Bryceson AD; Pinching AJ
    Q J Med; 1990 Nov; 77(283):1101-11. PubMed ID: 2274656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients.
    García-García JA; Martín-Sánchez J; Gállego M; Rivero-Román A; Camacho A; Riera C; Morillas-Márquez F; Vergara S; Macías J; Pineda JA
    J Clin Microbiol; 2006 Dec; 44(12):4455-8. PubMed ID: 17050814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.